+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Huntington Disease Drug"

From
From
Huntington's Disease Treatment Market Forecasts from 2023 to 2028 - Product Thumbnail Image

Huntington's Disease Treatment Market Forecasts from 2023 to 2028

  • Report
  • November 2023
  • 145 Pages
  • Global
From
United States AUSTEDO Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

United States AUSTEDO Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • January 2023
  • 30 Pages
  • United States
From
Ingrezza Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

Ingrezza Emerging Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • December 2022
  • 30 Pages
  • Global
From
Global Huntington's Disease - Pipeline Insight, 2022 - Product Thumbnail Image

Global Huntington's Disease - Pipeline Insight, 2022

  • Drug Pipelines
  • August 2022
  • 150 Pages
  • Global
From
From
Huntington's Disease - Epidemiology Forecast to 2032 - Product Thumbnail Image

Huntington's Disease - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
Market Spotlight: Huntington's Disease - Product Thumbnail Image

Market Spotlight: Huntington's Disease

  • Report
  • January 2021
  • 32 Pages
  • Global
From
From
From
Loading Indicator

The Huntington Disease Drug market is a subset of the Central Nervous System Drugs market. It is composed of drugs used to treat Huntington Disease, a rare, inherited neurological disorder that causes the progressive breakdown of nerve cells in the brain. Symptoms of the disease include involuntary movements, cognitive decline, and psychiatric disturbances. Currently, there is no cure for Huntington Disease, but medications can help manage symptoms and slow the progression of the disease. The Huntington Disease Drug market is composed of both branded and generic drugs. Branded drugs are typically more expensive than generic drugs, but they may offer more effective symptom management. The market is highly competitive, with many companies vying for market share. Some companies in the Huntington Disease Drug market include AbbVie, Teva Pharmaceuticals, and Lundbeck. Show Less Read more